AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

11 recruiting trials

for B-cell Mediated Autoimmune Disorders

Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases NCT07322718EARLY Phase 11 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: RXIM002 product Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA) NCT07629596EARLY Phase 11 site๐Ÿ“ Beijing Circunited BioPharma (Shenzhen) Co., Ltd. ยท Tests: Arnovie101 Infusion Intravenous Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676Phase 11 site๐Ÿ“ Jerusalem Polina Stepensky ยท Tests: HBI0101 CART Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease NCT07148791Phase 21 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: Anti-BCMA-CD19 CAR-T cells Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel NCT07577583n/a1 site๐Ÿ“ Morrisville TG Therapeutics, Inc. ยท Tests: No Intervention Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease NCT06792799EARLY Phase 11 site๐Ÿ“ Hangzhou The Children's Hospital of Zhejiang University School of Meโ€ฆ ยท Tests: anti-CD19/BCMA CAR NK cells (KN5601) A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease NCT06308978Phase 121 sites๐Ÿ“ Beverly Hills๐Ÿ“ Fullerton๐Ÿ“ Irvine Fate Therapeutics ยท Tests: FT819, Fludarabine, Cyclophosphamide, Bendamustine CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease NCT07305116Phase 11 site๐Ÿ“ Hangzhou The Children's Hospital of Zhejiang University School of Meโ€ฆ ยท Tests: UCAR T-cell A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders NCT06680037Phase 18 sites๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor๐Ÿ“ Omaha TG Therapeutics, Inc. ยท Tests: Azercabtagene zapreleucel (azer-cel) A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy NCT06249438Phase 11 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: CD20/BCMA-directed CAR-T cells CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease NCT06347718Phase 1, Phase 21 site๐Ÿ“ Erlangen Miltenyi Biomedicine GmbH ยท Tests: anti-CD19 CAR T cell therapy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy